Quetiapine and the need for a thorough QT/QTc study

J Clin Psychopharmacol. 2014 Feb;34(1):3-6. doi: 10.1097/JCP.0000000000000075.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Animals
  • Antipsychotic Agents / adverse effects*
  • Dibenzothiazepines / adverse effects*
  • ERG1 Potassium Channel
  • Ether-A-Go-Go Potassium Channels / antagonists & inhibitors
  • Ether-A-Go-Go Potassium Channels / metabolism
  • Evidence-Based Medicine
  • Heart Conduction System / drug effects*
  • Heart Conduction System / metabolism
  • Heart Conduction System / physiopathology
  • Humans
  • Long QT Syndrome / chemically induced*
  • Long QT Syndrome / metabolism
  • Long QT Syndrome / physiopathology
  • Potassium Channel Blockers / adverse effects
  • Quetiapine Fumarate
  • Risk Assessment
  • Risk Factors
  • Torsades de Pointes / chemically induced*
  • Torsades de Pointes / metabolism
  • Torsades de Pointes / physiopathology

Substances

  • Antipsychotic Agents
  • Dibenzothiazepines
  • ERG1 Potassium Channel
  • Ether-A-Go-Go Potassium Channels
  • Potassium Channel Blockers
  • Quetiapine Fumarate